AstraZeneca buys Chinese Gracell Biotechnologies for $1.2bn
Pharmaceutical giant AstrazZeneca wants to take over the Chinese company Gracell Biotechnologies in order to strengthen its cell therapy projects in a deal worth up to $1.2bn.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1352 entries already.
Entries by Thomas Gabrielczyk
Metrion Biosciences closes £3.7m equity financing
/in News/by Thomas GabrielczykCambridge-based Metrion Biosciences Ltd has secured £3.5m in new equity financing – led by Maven Capital Partners and a £1m contribution from existing investor, Gresham House Ventures.
LimmaTech Biologics acquires licence option for AbVacc vaccine LBT-SA7
/in News/by Thomas GabrielczykSwiss LimmaTech Biologics and AbVacc Inc have agreed to co-develop AbVacc’s preclinical <i>Staphylococcus aureus vaccine </i><span style="caret-color: rgb(33, 33, 33); color: rgb(33, 33, 33); font-family: Arial, sans-serif; font-size: 13.333333015441895px; font-style: […]
French parliamentarians against cell-based meat
/in News/by Thomas GabrielczykThe French Republicans have tabled a bill in the National Assembly aimed at banning the commercialisation of cell-based meat in France.
Vandria SA bags CHF18m in Series A financing
/in News/by Thomas GabrielczykLausanne-based Vandria SA has cashed in CHF18m in a Series A financing led by ND Capital to drive clinical development of VNA-318.
Antabio SAS raises €25 m in Series B financing
/in News/by Thomas Gabrielczyk<a title="http://www.b3cnewswire.com/PRT/link.php?click=1619-2-24039-8B20BDBA70E6BDF1B5F7FEECBC3EA611CB7D4F450000" target="_blank" rel="nofollow noopener" href="http://www.b3cnewswire.com/PRT/link.php?click=1619-2-24039-8B20BDBA70E6BDF1B5F7FEECBC3EA611CB7D4F450000">Antibiotics specialist Antabio SAS</a> has raised €25m in a Series B financing round with subscriptions from the AMR Action Fund, the EIC Fund and from […]
Production process for cell-based coffee published
/in News/by Thomas GabrielczykScientists led by Heiko Rischer from the Finnish research centre VTT have published the proof of concept for cell-based coffee production.
Germany blocks deregulation of NGT breeds
/in News/by Thomas GabrielczykAt the EU Council (10-11 December), agriculture ministers did not reach the qualified majority required to adopt the <link https://data.consilium.europa.eu/doc/document/ST-16443-2023-INIT/en/pdf>adapted version of the EU Commission’s draft regulation</link> on new genomic […]
Cathera SA closes Series B round at €42m
/in News/by Thomas GabrielczykSorbonne University spin-out Carthera SA has closed its Series B financing round with an additional investment of €4.5m at €42m to launch clinical trials.<br /> <br />
UK publishes £2bn vision for engineering biology
/in News/by Thomas GabrielczykOn the occasion of SynbiTECH in London, British Science, Research and Innovation Minister, Andrew Griffith, unveiled a £2bn strategic 10-year plan to foster engineering biology.